Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1993 Dec 11;307(6918):1505–1506. doi: 10.1136/bmj.307.6918.1505

Acromegaly: treatment after 100 years.

J A Wass
PMCID: PMC1679591  PMID: 8274912

Full text

PDF
1505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barkan A. L., Kelch R. P., Hopwood N. J., Beitins I. Z. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 1988 Jan;66(1):16–23. doi: 10.1210/jcem-66-1-16. [DOI] [PubMed] [Google Scholar]
  2. Bates A. S., Van't Hoff W., Jones J. M., Clayton R. N. An audit of outcome of treatment in acromegaly. Q J Med. 1993 May;86(5):293–299. [PubMed] [Google Scholar]
  3. Bengtsson B. A., Edén S., Ernest I., Odén A., Sjögren B. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand. 1988;223(4):327–335. doi: 10.1111/j.0954-6820.1988.tb15881.x. [DOI] [PubMed] [Google Scholar]
  4. Brada M., Ford D., Ashley S., Bliss J. M., Crowley S., Mason M., Rajan B., Traish D. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ. 1992 May 23;304(6838):1343–1346. doi: 10.1136/bmj.304.6838.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis D. H., Laws E. R., Jr, Ilstrup D. M., Speed J. K., Caruso M., Shaw E. G., Abboud C. F., Scheithauer B. W., Root L. M., Schleck C. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg. 1993 Jul;79(1):70–75. doi: 10.3171/jns.1993.79.1.0070. [DOI] [PubMed] [Google Scholar]
  6. Dobrashian R. D., O'Halloran D. J., Hunt A., Beardwell C. G., Shalet S. M. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol (Oxf) 1993 Jun;38(6):589–593. doi: 10.1111/j.1365-2265.1993.tb02139.x. [DOI] [PubMed] [Google Scholar]
  7. Dowling R. H., Hussaini S. H., Murphy G. M., Besser G. M., Wass J. A. Gallstones during octreotide therapy. Metabolism. 1992 Sep;41(9 Suppl 2):22–33. doi: 10.1016/0026-0495(92)90027-8. [DOI] [PubMed] [Google Scholar]
  8. Eastman R. C., Gorden P., Glatstein E., Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am. 1992 Sep;21(3):693–712. [PubMed] [Google Scholar]
  9. Fahlbusch R., Honegger J., Buchfelder M. Surgical management of acromegaly. Endocrinol Metab Clin North Am. 1992 Sep;21(3):669–692. [PubMed] [Google Scholar]
  10. Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol (Oxf) 1991 Nov;35(5):379–397. doi: 10.1111/j.1365-2265.1991.tb03554.x. [DOI] [PubMed] [Google Scholar]
  11. Lamberts S. W. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev. 1988 Nov;9(4):417–436. doi: 10.1210/edrv-9-4-417. [DOI] [PubMed] [Google Scholar]
  12. Lamberts S. W., Zweens M., Verschoor L., del Pozo E. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs. J Clin Endocrinol Metab. 1986 Jul;63(1):16–19. doi: 10.1210/jcem-63-1-16. [DOI] [PubMed] [Google Scholar]
  13. Markussis V., Beshyah S. A., Fisher C., Sharp P., Nicolaides A. N., Johnston D. G. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 1992 Nov 14;340(8829):1188–1192. doi: 10.1016/0140-6736(92)92892-j. [DOI] [PubMed] [Google Scholar]
  14. Molitch M. E. Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am. 1992 Sep;21(3):597–614. [PubMed] [Google Scholar]
  15. Spada A., Arosio M., Bochicchio D., Bazzoni N., Vallar L., Bassetti M., Faglia G. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab. 1990 Dec;71(6):1421–1426. doi: 10.1210/jcem-71-6-1421. [DOI] [PubMed] [Google Scholar]
  16. Wass J. A., Laws E. R., Jr, Randall R. V., Sheline G. E. The treatment of acromegaly. Clin Endocrinol Metab. 1986 Aug;15(3):683–707. doi: 10.1016/s0300-595x(86)80015-9. [DOI] [PubMed] [Google Scholar]
  17. Wass J. A., Thorner M. O., Morris D. V., Rees L. H., Mason A. S., Jones A. E., Besser G. M. Long-term treatment of acromegaly with bromocriptine. Br Med J. 1977 Apr 2;1(6065):875–878. doi: 10.1136/bmj.1.6065.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. van der Lely A. J., Harris A. G., Lamberts S. W. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clin Endocrinol (Oxf) 1992 Aug;37(2):181–185. doi: 10.1111/j.1365-2265.1992.tb02304.x. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES